Clinical Trial: Tyrosine kinase inhibitor de-escalation strategy (dose reduction vs. discontinuation) before treatment cessation in patients with chronic myeloid leukemia (China)

Posted On: 2026-08-19

China, Aug. 19 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Tyrosine kinase inhibitor de-escalation strategy (dose reduction vs. discontinuation) before treatment cessation in patients with chronic myeloid leukemia'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130262

Registration Time: 2026/08/18

Type: Interventional study

Primary Sponsor: Southern Medical University Southern Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336479

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया हमे संपर्क करें.

विशेष

Category

Source

Publication

Location

Clinical Trial: Tyrosine kinase inhibitor de-escalation strategy (dose reduction vs. discontinuation) before treatment cessation in patients with chronic myeloid leukemia (China)